CANCER

The mission of the CANCER structured Program is to create a platform of integrated competences that promotes translation of basic research to clinical application in the area of oncology. The strategy for development of this program relies on building a conceptual scientific and technologic platform, where integration between basic and applied research is fostered. The CANCER Program will also rely on our well-established collaborations with the pharmaceutical and in vitro diagnostics industry to boost the likelihood of creating economic value, hence complying with the smart specialization RIS3 strategy for Norte Portugal. Numerous researchers from four institutions Ipatimup/i3S, IBMC/i3S, INL and CINTESIS under the co-ordination of Ipatimup/i3S, are involved in this program with five research lines in co-promotion:
1- Novel therapeutic targets and models for cancer;
2- Dynamics of intra-tumor heterogeneity;
3- Determinants of cell invasion and metastization in cancer;
4- Innovative biomarkers for cancer diagnosis, prognosis and therapy optimization;
5- Microsystem platforms for early cancer diagnosis & disease progression monitoring.